Kayoko Kubota

618 total citations
30 papers, 433 citations indexed

About

Kayoko Kubota is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Kayoko Kubota has authored 30 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 18 papers in Cardiology and Cardiovascular Medicine and 8 papers in Oncology. Recurrent topics in Kayoko Kubota's work include Pulmonary Hypertension Research and Treatments (14 papers), Cardiovascular Function and Risk Factors (13 papers) and Lung Cancer Treatments and Mutations (7 papers). Kayoko Kubota is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), Cardiovascular Function and Risk Factors (13 papers) and Lung Cancer Treatments and Mutations (7 papers). Kayoko Kubota collaborates with scholars based in Japan and United States. Kayoko Kubota's co-authors include Chuwa Tei, Mitsuru Ohishi, Ryuzo Sakata, Tetsuya Ueno, Yutaka Otsuji, Robert A. Levine, Masaaki Miyata, Toshinori Yuasa, Kunitsugu Takasaki and Akira Kisanuki and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kayoko Kubota

26 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kayoko Kubota Japan	10	326	182	134	100	58	30	433
Gerhard Kalweit Germany	13	144 0.4×	152 0.8×	147 1.1×	45 0.5×	68 1.2×	31	422
Edward El‐Am United States	12	219 0.7×	92 0.5×	60 0.4×	85 0.8×	79 1.4×	47	419
Sara Ferreira Portugal	10	209 0.6×	86 0.5×	70 0.5×	61 0.6×	29 0.5×	43	350
Wanzhen Zeng Canada	9	118 0.4×	153 0.8×	107 0.8×	29 0.3×	25 0.4×	28	319
Nikolaos Galanakis Greece	12	138 0.4×	134 0.7×	247 1.8×	35 0.3×	39 0.7×	47	395
Gregory Hartlage United States	11	377 1.2×	141 0.8×	118 0.9×	87 0.9×	79 1.4×	23	500
Kenji Kawamoto Japan	12	146 0.4×	288 1.6×	183 1.4×	36 0.4×	56 1.0×	34	485
Carlos A. Gongora United States	11	228 0.7×	160 0.9×	156 1.2×	17 0.2×	118 2.0×	35	472
Ceyhun Ceyhan Türkiye	9	238 0.7×	81 0.4×	126 0.9×	39 0.4×	43 0.7×	29	385
Muhammed Ulvi Yalçın Türkiye	15	411 1.3×	105 0.6×	50 0.4×	38 0.4×	60 1.0×	40	598

Countries citing papers authored by Kayoko Kubota

Since Specialization

Citations

This map shows the geographic impact of Kayoko Kubota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayoko Kubota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayoko Kubota more than expected).

Fields of papers citing papers by Kayoko Kubota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayoko Kubota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayoko Kubota. The network helps show where Kayoko Kubota may publish in the future.

Co-authorship network of co-authors of Kayoko Kubota

This figure shows the co-authorship network connecting the top 25 collaborators of Kayoko Kubota. A scholar is included among the top collaborators of Kayoko Kubota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kayoko Kubota. Kayoko Kubota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shimokawahara, Hiroto, Mari Nishizaki, Takumi Inami, et al.. (2025). Effect of riociguat on exercise following balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension in Japan (THERAPY-HYBRID-BPA): a multicentre, double-blind, randomised, controlled, phase 4 trial. The Lancet Respiratory Medicine. 13(9). 789–799.

Tamura, Yuichi, Kazuya Hosokawa, Satoshi Ikeda, et al.. (2024). Development and Validation of Quality Indicators for Pulmonary Arterial Hypertension Management in Japan: A Modified Delphi Consensus Study. Diagnostics. 14(23). 2656–2656. 1 indexed citations

Shimokawahara, Hiroto, Takumi Inami, Kayoko Kubota, et al.. (2023). Protocol for a multicentre, double-blind, randomised, placebo-controlled trial of riociguat on peak cardiac index during exercise in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty (THERAPY-HYBRID-BPA trial). BMJ Open. 13(7). e072241–e072241. 7 indexed citations

Kubota, Kayoko, et al.. (2023). Association of delayed diagnosis of pulmonary arterial hypertension with its prognosis. Journal of Cardiology. 83(6). 365–370. 9 indexed citations

Kubota, Kayoko, et al.. (2022). Unknown atrial septal defect was diagnosed during the course of treatment for portopulmonary hypertension: A case report. Journal of Cardiology Cases. 26(5). 383–385.

Kubota, Kayoko, et al.. (2021). Different characteristics of mitochondrial dynamics-related miRNAs on the hemodynamics of pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension. Journal of Cardiology. 78(1). 24–30. 7 indexed citations

Kubota, Kayoko, et al.. (2020). Geriatric Nutritional Risk Index Is Associated With Prognosis in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension. Circulation Reports. 2(7). 372–377. 9 indexed citations

Kubota, Kayoko, et al.. (2020). The potential for early diagnosis of pulmonary arterial hypertension using lung iodine-123-metaiodobenzylguanidine (123I-MIBG) uptake: A case report. SHILAP Revista de lepidopterología. 15(8). 1164–1167. 2 indexed citations

Kubota, Kayoko, et al.. (2019). Predictors of exercise-induced pulmonary hypertension in patients with connective tissue disease. Heart and Vessels. 34(9). 1509–1518. 5 indexed citations

10.

Yuasa, Toshinori, Masaaki Miyata, Kayoko Kubota, et al.. (2019). Correlation of Right Ventricular Wall Stress With Plasma B-Type Natriuretic Peptide Levels in Patients With Pulmonary Hypertension. Circulation Journal. 83(6). 1278–1285. 8 indexed citations

11.

Horinouchi, Hidehito, Kayoko Kubota, Shinji Nakamichi, et al.. (2013). Short Hydration in Chemotherapy Containing Cisplatin (>=75 mg/m2) for Patients with Lung Cancer: A Prospective Study. Japanese Journal of Clinical Oncology. 43(11). 1105–1109. 40 indexed citations

12.

Otsuji, Yutaka, Ryuzo Sakata, Kayoko Kubota, et al.. (2011). Reply to the Editor. Journal of Thoracic and Cardiovascular Surgery. 141(2). 602–603.

13.

Kubota, Kayoko, Yutaka Otsuji, Tetsuya Ueno, et al.. (2010). Functional mitral stenosis after surgical annuloplasty for ischemic mitral regurgitation: Importance of subvalvular tethering in the mechanism and dynamic deterioration during exertion. Journal of Thoracic and Cardiovascular Surgery. 140(3). 617–623. 56 indexed citations

14.

Kisanuki, Akira, Kayoko Kubota, Eiji Kuwahara, et al.. (2010). Left ventricular global systolic dysfunction has a significant role in the development of diastolic heart failure in patients with systemic hypertension. Hypertension Research. 33(11). 1167–1173. 9 indexed citations

15.

Kisanuki, Akira, Kunitsugu Takasaki, Toshinori Yuasa, et al.. (2009). Left ventricular systolic function is abnormal in diastolic heart failure: Re-assessment of systolic function using cardiac time interval analysis. Journal of Cardiology. 53(3). 437–446. 19 indexed citations

16.

Hori, Katsuhito, et al.. (2008). Analysis of Adverse Drug Reactions due to Amrubicin Chemotherapy in Lung Cancer Patients. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 34(2). 95–102.

17.

Kuwahara, Eiji, Yutaka Otsuji, Yoshifumi Iguro, et al.. (2006). Mechanism of Recurrent/Persistent Ischemic/Functional Mitral Regurgitation in the Chronic Phase After Surgical Annuloplasty. Circulation. 114(1_supplement). I529–34. 147 indexed citations

18.

Ishikura, Satoshi, Yuichiro Ohe, Keiji Nihei, et al.. (2003). 779 A pilot study of hyperfractionated accelerated radiotherapy (HART) following induction cisplatin and vinorelbine for stage III non-small cell lung cancer (NSCLC). European Journal of Cancer Supplements. 1(5). S234–S234. 1 indexed citations

19.

Kubota, Kayoko, Yuichiro Ohe, Hajime Watanabe, et al.. (2000). Phase I study of weekly docetaxel (DTX) and carboplatin (CBDCA) with concurrent thoracic radiotherapy (TRT) for stage III non-small cell lung cancer (NSCLC). Lung Cancer. 29(1). 111–111. 9 indexed citations

20.

Kusaba, Hitoshi, Yuya Nakamura, Hideo Kunitoh, et al.. (2000). A phase II trial of low-dose docetaxel (DCT) 60 mg/m2 in platinum-pretreated advanced non-small cell lung cancer (NSCLC). Lung Cancer. 29(1). 25–25. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact